Skip to Content

Amphotericin b lipid complex Pregnancy and Breastfeeding Warnings

Amphotericin b lipid complex is also known as: Abelcet

Amphotericin b lipid complex Pregnancy Warnings

Amphotericin B lipid complex has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Amphotericin B lipid complex should only be given during pregnancy when benefit outweighs risk.

See references

Amphotericin b lipid complex Breastfeeding Warnings

There are no data on the excretion of amphotericin B lipid complex into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from amphotericin B lipid complex, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Abelcet (amphotericin B)." Liposome Company Inc, The, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Abelcet (amphotericin B)." Liposome Company Inc, The, Princeton, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide